{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 20779, "items": [{"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T07:46:46Z", "timestamp": 1575100006467}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "11", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Antimicrobial Agents and Chemotherapy"], "published-print": {"date-parts": [[2003, 11, 1]]}, "DOI": "10.1128/aac.47.11.3464-3469.2003", "type": "journal-article", "created": {"date-parts": [[2003, 10, 24]], "date-time": "2003-10-24T02:33:30Z", "timestamp": 1066962810000}, "page": "3464-3469", "source": "Crossref", "is-referenced-by-count": 18, "title": ["Chloramphenicol Is a Potent Inhibitor of Cytochrome P450 Isoforms CYP2C19 and CYP3A4 in Human Liver Microsomes"], "prefix": "10.1128", "volume": "47", "author": [{"given": "J.-Y.", "family": "Park", "sequence": "first", "affiliation": []}, {"given": "K.-A.", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "S.-L.", "family": "Kim", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[2003, 10, 23]]}, "container-title": ["Antimicrobial Agents and Chemotherapy"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/AAC.47.11.3464-3469.2003", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T16:08:27Z", "timestamp": 1482509307000}, "score": 68.74204, "issued": {"date-parts": [[2003, 10, 23]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 11, 1]]}, "issue": "11"}, "URL": "http://dx.doi.org/10.1128/aac.47.11.3464-3469.2003", "ISSN": ["0066-4804", "1098-6596"], "issn-type": [{"value": "0066-4804", "type": "print"}, {"value": "1098-6596", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology", "Infectious Diseases"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T13:50:03Z", "timestamp": 1574171403474}, "reference-count": 29, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Metab Dispos"], "published-print": {"date-parts": [[2003, 9]]}, "DOI": "10.1124/dmd.31.9.1090", "type": "journal-article", "created": {"date-parts": [[2003, 8, 14]], "date-time": "2003-08-14T23:48:39Z", "timestamp": 1060904919000}, "page": "1090-1092", "source": "Crossref", "is-referenced-by-count": 17, "title": ["INHIBITORY EFFECT OF GLYBURIDE ON HUMAN CYTOCHROME P450 ISOFORMS IN HUMAN LIVER MICROSOMES"], "prefix": "10.1124", "volume": "31", "author": [{"given": "Kyoung-Ah", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Ji-Young", "family": "Park", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2003, 8, 14]]}, "reference": [{"key": "2019091113311090000_31.9.1090.1", "volume": "84", "first-page": "102", "year": "1991", "journal-title": "South Med J"}, {"key": "2019091113311090000_31.9.1090.2", "DOI": "10.2165/00002018-199818020-00001", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.3", "volume": "24", "first-page": "412", "year": "1983", "journal-title": "Diabetologia"}, {"key": "2019091113311090000_31.9.1090.4", "volume": "24", "first-page": "1401", "year": "1996", "journal-title": "Drug Metab\n Dispos"}, {"key": "2019091113311090000_31.9.1090.5", "volume": "277", "first-page": "321", "year": "1996", "journal-title": "J\n Pharmacol Exp Ther"}, {"key": "2019091113311090000_31.9.1090.6", "unstructured": "Brian WR (2000) Hypoglycemic agents, in Metabolic Drug Interactions (Levy RH, Thummel KE, Trager WF, Hansten PD, and Eichelbaum M eds) pp 529-543, Lippincott Williams & Wilkins, Philadelphia, PA."}, {"key": "2019091113311090000_31.9.1090.7", "volume": "28", "first-page": "29", "year": "1989", "journal-title": "Br J Clin\n Pharmacol", "DOI": "10.1111/j.1365-2125.1989.tb03502.x", "doi-asserted-by": "crossref"}, {"key": "2019091113311090000_31.9.1090.8", "volume": "27", "first-page": "180", "year": "1999", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113311090000_31.9.1090.9", "volume": "54", "first-page": "4026", "year": "1994", "journal-title": "Cancer Res"}, {"key": "2019091113311090000_31.9.1090.10", "volume": "18", "first-page": "624", "year": "1996", "journal-title": "Ther Drug\n Monit", "DOI": "10.1097/00007691-199610000-00017", "doi-asserted-by": "crossref"}, {"key": "2019091113311090000_31.9.1090.11", "DOI": "10.1136/bmj.303.6805.789-a", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.12", "DOI": "10.1007/s002280000214", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.13", "DOI": "10.1016/S0163-7258(96)00140-4", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.14", "volume": "23", "first-page": "743", "year": "1987", "journal-title": "Br J Clin\n Pharmacol", "DOI": "10.1111/j.1365-2125.1987.tb03110.x", "doi-asserted-by": "crossref"}, {"key": "2019091113311090000_31.9.1090.15", "volume": "24", "first-page": "414", "year": "1996", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113311090000_31.9.1090.16", "volume": "37", "first-page": "437", "year": "1982", "journal-title": "Therapie"}, {"key": "2019091113311090000_31.9.1090.17", "DOI": "10.1046/j.1365-2125.1998.00721.x", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.18", "DOI": "10.1021/tx00025a009", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.19", "volume": "96", "first-page": "1443", "year": "1989", "journal-title": "Chest"}, {"key": "2019091113311090000_31.9.1090.20", "DOI": "10.1124/dmd.30.10.1102", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.21", "volume": "27", "first-page": "1078", "year": "1999", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113311090000_31.9.1090.22", "volume": "45", "first-page": "1034", "year": "2002", "journal-title": "Diabetologia", "DOI": "10.1007/s00125-002-0855-0", "doi-asserted-by": "crossref"}, {"key": "2019091113311090000_31.9.1090.23", "volume": "265", "first-page": "401", "year": "1993", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019091113311090000_31.9.1090.24", "volume": "271", "first-page": "549", "year": "1994", "journal-title": "J Pharmacol Exp\n Ther"}, {"key": "2019091113311090000_31.9.1090.25", "volume": "36", "first-page": "783", "year": "1996", "journal-title": "J Clin Pharmacol", "DOI": "10.1002/j.1552-4604.1996.tb04251.x", "doi-asserted-by": "crossref"}, {"key": "2019091113311090000_31.9.1090.26", "DOI": "10.1016/S0006-2952(97)00239-6", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.27", "volume": "29", "first-page": "1359", "year": "2001", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113311090000_31.9.1090.28", "DOI": "10.1006/abbi.1993.1506", "doi-asserted-by": "publisher"}, {"key": "2019091113311090000_31.9.1090.29", "DOI": "10.1016/S0006-2952(97)00304-3", "doi-asserted-by": "publisher"}], "container-title": ["Drug Metabolism and Disposition"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/dmd.31.9.1090", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 11]], "date-time": "2019-09-11T20:39:29Z", "timestamp": 1568234369000}, "score": 46.610844, "issued": {"date-parts": [[2003, 8, 14]]}, "references-count": 29, "journal-issue": {"published-online": {"date-parts": [[2003, 8, 14]]}, "published-print": {"date-parts": [[2003, 9]]}, "issue": "9"}, "alternative-id": ["10.1124/dmd.31.9.1090"], "URL": "http://dx.doi.org/10.1124/dmd.31.9.1090", "relation": {"cites": []}, "ISSN": ["0090-9556", "1521-009X"], "issn-type": [{"value": "0090-9556", "type": "print"}, {"value": "1521-009X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T20:02:57Z", "timestamp": 1575316977903}, "reference-count": 18, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 8, 1]], "date-time": "2003-08-01T00:00:00Z", "timestamp": 1059696000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Arch Pharm Res"], "published-print": {"date-parts": [[2003, 8]]}, "DOI": "10.1007/bf02976712", "type": "journal-article", "created": {"date-parts": [[2008, 10, 30]], "date-time": "2008-10-30T07:37:19Z", "timestamp": 1225352239000}, "page": "631-637", "source": "Crossref", "is-referenced-by-count": 47, "title": ["Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes"], "prefix": "10.1007", "volume": "26", "author": [{"given": "Kyoung-Ah", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Ji-Young", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Ji-Suk", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Sabina", "family": "Lim", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"issue": "3", "key": "BF02976712_CR1", "doi-asserted-by": "crossref", "first-page": "237", "DOI": "10.1067/mcp.2000.104257", "volume": "67", "author": "O. G. Ademowo", "year": "2000", "unstructured": "Ademowo, O. G., Sodeinde, O., and Walker, O., The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: evidence for decreased chloroquine metabolism in volunteers with pruritus.Clin. Pharmacol. Ther., 67 (3), 237\u2013241 (2000).", "journal-title": "Clin. Pharmacol. Ther."}, {"issue": "4", "key": "BF02976712_CR2", "first-page": "429", "volume": "42", "author": "P. Augustijns", "year": "1992", "unstructured": "Augustijns, P., Geusens, P., and Verbeke, N., Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis.Eur. J. Clin. Pharmacol., 42 (4), 429\u2013433 (1992).", "journal-title": "Eur. J. Clin. Pharmacol."}, {"issue": "1", "key": "BF02976712_CR3", "first-page": "321", "volume": "277", "author": "M. Bourrie", "year": "1996", "unstructured": "Bourrie, M., Meunier, V., Berger, Y., and Fabre, G., Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.J. Pharmacol. Exp. Ther. 277 (1), 321\u2013332 (1996).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BF02976712_CR4", "doi-asserted-by": "crossref", "first-page": "29", "DOI": "10.1111/j.1365-2125.1989.tb03502.x", "volume": "28", "author": "R. Broly", "year": "1989", "unstructured": "Broly, R., Libersa, C., Lhermitte, M., Bechtel, P., and Dupuis, B., Effect of quinidine on the dextromethorpha.O-demethylase activity of microsomal fractions from human liver.Br. J. Clin. Pharmacol., 28, 29\u201336 (1989).", "journal-title": "Br. J. Clin. Pharmacol."}, {"issue": "(1-2)", "key": "BF02976712_CR5", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1016/S0378-4347(97)00273-9", "volume": "698", "author": "J. Ducharme", "year": "1997", "unstructured": "Ducharme, J. and Farinotti, R., Rapid and simple method to determine chloroquine and its desethylated metabolites in human microsomes by high-performance liquid chromatography with fluorescence detection.J. Chromatogr. B Biomed. Sci. Appl., 698 (1-2), 243\u2013250 (1997).", "journal-title": "J. Chromatogr. B Biomed. Sci. Appl."}, {"issue": "2", "key": "BF02976712_CR6", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1046/j.1365-2125.1998.00679.x", "volume": "45", "author": "V. A. Eagling", "year": "1998", "unstructured": "Eagling, V. A., Tjia, J. R., and Back, D. J., Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.Br. J. Clin. Pharmacol., 45 (2), 107\u2013114 (1998).", "journal-title": "Br. J. Clin. Pharmacol."}, {"issue": "10", "key": "BF02976712_CR7", "doi-asserted-by": "crossref", "first-page": "813", "DOI": "10.1002/j.1552-4604.1987.tb03002.x", "volume": "27", "author": "E. I. Ette", "year": "1987", "unstructured": "Ette, E. I., Brown-Awala, E. A., and Essien, E. E., Chloroquine elimination in humans: effect of low-dose cimetidine.J. Clin. Pharmacol., 27 (10), 813\u2013816 (1987).", "journal-title": "J. Clin. Pharmacol."}, {"issue": "5", "key": "BF02976712_CR8", "doi-asserted-by": "crossref", "first-page": "457", "DOI": "10.1002/j.1552-4604.1989.tb03362.x", "volume": "29", "author": "E. I. Ette", "year": "1989", "unstructured": "Ette, E. I., Essien, E. E., Thomas, W.O., and Brown-Awala, E.A., Pharmacokinetics of chloroquine and some of its metabolites in healthy volunteers: a single dose study.J. Clin. Pharmacol., 29 (5), 457\u2013462 (1989).", "journal-title": "J. Clin. Pharmacol."}, {"issue": "4", "key": "BF02976712_CR9", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1007/BF00542151", "volume": "26", "author": "M. Frisk-Holmberg", "year": "1984", "unstructured": "Frisk-Holmberg, M., Bergqvist, Y., Termond, E., and Domeij-Nyberg, B., The single dose kinetics of chloroquine and its major metabolite desethylchloroquine in healthy subjects.Eur. J. Clin. Pharmacol., 26 (4), 521\u2013530 (1984).", "journal-title": "Eur. J. Clin. Pharmacol."}, {"issue": "4", "key": "BF02976712_CR10", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1111/j.1365-2125.1983.tb01532.x", "volume": "15", "author": "L. L. Gustafsson", "year": "1983", "unstructured": "Gustafsson, L. L., Walker, O., Alvan, G., Beermann, B., Estevez, F., Gleisner, L., Lindstrom, B., and Sjoqvist, R., Disposition of chloroquine in man after single intravenous and oral doses.Br. J. Clin. Pharmacol., 15 (4), 471\u2013479 (1983).", "journal-title": "Br. J. Clin. Pharmacol."}, {"key": "BF02976712_CR11", "first-page": "4026", "volume": "54", "author": "J. W. Harris", "year": "1994", "unstructured": "Harris, J. W., Rahman, A., Kim, B. R., Guengerich, F. P., and Collins, J. M., Metabolism of taxol by human hepatic microsomes and liver slices: participation of cytochrome P450 3A4 and an unknown P450 enzyme.Cancer Res., 54, 4026\u20134035 (1994).", "journal-title": "Cancer Res."}, {"issue": "8450", "key": "BF02976712_CR12", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1016/S0140-6736(85)90377-0", "volume": "2", "author": "D. Ofori-Adjei", "year": "1985", "unstructured": "Ofori-Adjei D. and Ericsson, O., Chloroquine in nail clippings.Lancet, 2 (8450), 331 (1985).", "journal-title": "Lancet"}, {"issue": "2", "key": "BF02976712_CR13", "doi-asserted-by": "crossref", "first-page": "195", "DOI": "10.1016/S0928-0987(01)00108-7", "volume": "13", "author": "C. O. Onyeji", "year": "2001", "unstructured": "Onyeji, C. O. and Ogunbona, F A., Pharmacokinetic aspects of chloroquine-induced pruritus: influence of dose and evidence for varied extent of metabolism of the drug.Eur. J. Pharm. Sci., 13 (2), 195\u2013201 (2001).", "journal-title": "Eur. J. Pharm. Sci."}, {"issue": "1", "key": "BF02976712_CR14", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1097/00007691-199302000-00008", "volume": "15", "author": "C. O. Onyeji", "year": "1993", "unstructured": "Onyeji, C. O., Toriola, T. A., and Ogunbona, F A., Lack of pharmacokinetic interaction between chloroquine and imipramine.Ther. Drug Monit., 15 (1), 43\u201346 (1993).", "journal-title": "Ther. Drug Monit."}, {"issue": "1", "key": "BF02976712_CR15", "first-page": "414", "volume": "270", "author": "T. Shimada", "year": "1994", "unstructured": "Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P., Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.J. Pharmacol. Exp. Ther., 270 (1), 414\u2013423 (1994).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BF02976712_CR16", "first-page": "401", "volume": "265", "author": "W. Tassaneeyakul", "year": "1993", "unstructured": "Tassaneeyakul W., Birkett D. J., Veronese M. E., McManus M. E., Tukey R. H., Quattrochi L. C., Gelboin H. V., and Miners J. O. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.J. Pharmacol. Exp. Ther., 265, 401\u2013407 (1993).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BF02976712_CR17", "first-page": "549", "volume": "271", "author": "K. E. Thummel", "year": "1994", "unstructured": "Thummel, K. E., Shen, D. D., Podoll, T. D., Kunze, K. L., Trager, W. F., Hartwell, P. S., Raisys, V. A., Marsh, C. L., McVicar, J. P., Barr, D. M., Perkins, J. D., and Cariers, R. L., Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.J. Pharmacol. Exp. Ther., 271, 549\u2013556 (1994).", "journal-title": "J. Pharmacol. Exp. Ther."}, {"key": "BF02976712_CR18", "doi-asserted-by": "crossref", "first-page": "240", "DOI": "10.1006/abbi.1993.1506", "volume": "306", "author": "S. A. Wrighton", "year": "1993", "unstructured": "Wrighton, S. A., Stevens, J. C., Becker, G. W., and Vandenbranden, M., Isolation and characterization of human cytochrome P4502C19: Correlation between 2C19 and S-mephenytoin 4\u2019-hydroxylation.Arch. Biochem. Biophys., 306, 240\u2013245 (1993).", "journal-title": "Arch. Biochem. Biophys."}], "container-title": ["Archives of Pharmacal Research"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/BF02976712.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/BF02976712/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/BF02976712", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 21]], "date-time": "2019-05-21T21:29:55Z", "timestamp": 1558474195000}, "score": 36.54527, "issued": {"date-parts": [[2003, 8]]}, "references-count": 18, "journal-issue": {"published-print": {"date-parts": [[2003, 8]]}, "issue": "8"}, "alternative-id": ["BF02976712"], "URL": "http://dx.doi.org/10.1007/bf02976712", "relation": {"cites": []}, "ISSN": ["0253-6269", "1976-3786"], "issn-type": [{"value": "0253-6269", "type": "print"}, {"value": "1976-3786", "type": "electronic"}], "subject": ["Organic Chemistry", "Molecular Medicine", "Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T18:23:52Z", "timestamp": 1574187832868}, "reference-count": 38, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "7", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Metab Dispos"], "published-print": {"date-parts": [[2006, 7]]}, "DOI": "10.1124/dmd.105.009134", "type": "journal-article", "created": {"date-parts": [[2006, 4, 1]], "date-time": "2006-04-01T01:34:08Z", "timestamp": 1143855248000}, "page": "1090-1095", "source": "Crossref", "is-referenced-by-count": 47, "title": ["STEREOSELECTIVE METABOLISM OF ENDOSULFAN BY HUMAN LIVER MICROSOMES AND HUMAN CYTOCHROME P450 ISOFORMS"], "prefix": "10.1124", "volume": "34", "author": [{"given": "Hwa-Kyung", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "Joon-Kwan", "family": "Moon", "sequence": "additional", "affiliation": []}, {"given": "Chul-Hee", "family": "Chang", "sequence": "additional", "affiliation": []}, {"given": "Hoon", "family": "Choi", "sequence": "additional", "affiliation": []}, {"given": "Hee-Won", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Byeoung-Soo", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Hye-Suk", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Eul-Chul", "family": "Hwang", "sequence": "additional", "affiliation": []}, {"given": "Young-Deuk", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Kwang-Hyeon", "family": "Liu", "sequence": "additional", "affiliation": []}, {"given": "Jeong-Han", "family": "Kim", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2006, 3, 31]]}, "reference": [{"key": "2019091113255984000_34.7.1090.1", "volume": "28", "first-page": "966", "year": "2000", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113255984000_34.7.1090.2", "DOI": "10.1007/s00253-003-1241-7", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.3", "DOI": "10.1093/jee/58.2.286", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.4", "DOI": "10.1124/dmd.104.001693", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.5", "DOI": "10.1016/0024-3205(91)90368-L", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.6", "DOI": "10.1016/0147-6513(81)90030-0", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.7", "volume": "28", "first-page": "1222", "year": "2000", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113255984000_34.7.1090.8", "volume": "9", "first-page": "295", "year": "1999", "journal-title": "Pharmacogenetics", "DOI": "10.1097/00008571-199906000-00004", "doi-asserted-by": "crossref"}, {"key": "2019091113255984000_34.7.1090.9", "DOI": "10.1006/abbi.2000.1708", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.10", "DOI": "10.1177/0091270004269142", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.11", "volume": "29", "first-page": "100", "year": "2001", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113255984000_34.7.1090.12", "DOI": "10.1002/(SICI)1099-0801(199701)11:1<33::AID-BMC618>3.0.CO;2-U", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.13", "volume": "30", "first-page": "683", "year": "2001", "journal-title": "J Environ Qual", "DOI": "10.2134/jeq2001.303683x", "doi-asserted-by": "crossref"}, {"key": "2019091113255984000_34.7.1090.14", "volume": "28", "first-page": "1287", "year": "2005", "journal-title": "Arch Pharm Res (Seoul)", "DOI": "10.1007/BF02978214", "doi-asserted-by": "crossref"}, {"key": "2019091113255984000_34.7.1090.15", "DOI": "10.1124/dmd.31.10.1227", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.16", "DOI": "10.1002/rcm.2110", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.17", "volume": "62", "first-page": "593", "year": "1996", "journal-title": "Appl Environ Microbiol"}, {"key": "2019091113255984000_34.7.1090.18", "DOI": "10.1097/00008571-200107000-00004", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.19", "volume": "77", "first-page": "255", "year": "2003", "journal-title": "Arch Toxicol", "DOI": "10.1007/s00204-003-0442-2", "doi-asserted-by": "crossref"}, {"key": "2019091113255984000_34.7.1090.20", "DOI": "10.1002/ps.422", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.21", "DOI": "10.1016/0960-0760(93)90152-M", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.22", "DOI": "10.1016/S0378-4347(98)00411-3", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.23", "DOI": "10.1016/S0009-9236(98)90165-5", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.24", "volume": "29", "first-page": "127", "year": "2001", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113255984000_34.7.1090.25", "DOI": "10.1016/S0006-2952(98)00268-8", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.26", "volume": "270", "first-page": "414", "year": "1994", "journal-title": "J Pharmacol Exp Ther"}, {"key": "2019091113255984000_34.7.1090.27", "volume": "27", "first-page": "1078", "year": "1999", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113255984000_34.7.1090.28", "volume": "27", "first-page": "517", "year": "1999", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113255984000_34.7.1090.29", "volume": "25", "first-page": "1383", "year": "1997", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113255984000_34.7.1090.30", "DOI": "10.1128/AEM.66.7.2822-2828.2000", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.31", "DOI": "10.1016/j.cbi.2004.03.002", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.32", "volume": "29", "first-page": "1201", "year": "2001", "journal-title": "Drug Metab Dispos"}, {"key": "2019091113255984000_34.7.1090.33", "DOI": "10.1016/S0009-2797(02)00074-1", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.34", "DOI": "10.1016/j.cbi.2004.09.015", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.35", "DOI": "10.1124/dmd.32.3.333", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.36", "DOI": "10.1124/jpet.103.049601", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.37", "DOI": "10.1006/bbrc.1999.0752", "doi-asserted-by": "publisher"}, {"key": "2019091113255984000_34.7.1090.38", "volume": "38", "first-page": "207", "year": "1990", "journal-title": "Mol Pharmacol"}], "container-title": ["Drug Metabolism and Disposition"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/dmd.105.009134", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 11]], "date-time": "2019-09-11T20:30:25Z", "timestamp": 1568233825000}, "score": 36.133, "issued": {"date-parts": [[2006, 3, 31]]}, "references-count": 38, "journal-issue": {"published-online": {"date-parts": [[2006, 6, 21]]}, "published-print": {"date-parts": [[2006, 7]]}, "issue": "7"}, "alternative-id": ["10.1124/dmd.105.009134"], "URL": "http://dx.doi.org/10.1124/dmd.105.009134", "relation": {"cites": []}, "ISSN": ["0090-9556", "1521-009X"], "issn-type": [{"value": "0090-9556", "type": "print"}, {"value": "1521-009X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:17:06Z", "timestamp": 1574137026495}, "reference-count": 36, "publisher": "Springer Science and Business Media LLC", "issue": "8", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2004, 9, 8]], "date-time": "2004-09-08T00:00:00Z", "timestamp": 1094601600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Eur J Clin Pharmacol"], "published-print": {"date-parts": [[2004, 10]]}, "DOI": "10.1007/s00228-004-0815-3", "type": "journal-article", "created": {"date-parts": [[2004, 9, 7]], "date-time": "2004-09-07T15:04:01Z", "timestamp": 1094569441000}, "page": "575-581", "source": "Crossref", "is-referenced-by-count": 56, "title": ["Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes"], "prefix": "10.1007", "volume": "60", "author": [{"given": "Kyoung-Ah", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Jaegul", "family": "Chung", "sequence": "additional", "affiliation": []}, {"given": "Dong-Hae", "family": "Jung", "sequence": "additional", "affiliation": []}, {"given": "Ji-Young", "family": "Park", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2004, 9, 8]]}, "reference": [{"key": "CR1", "doi-asserted-by": "crossref", "first-page": "27S", "DOI": "10.1016/S0002-9343(99)00279-X", "volume": "107", "author": "M Camilleri", "year": "1998", "unstructured": "Camilleri M (1998) Therapeutic approach to the patient with irritable bowel syndrome. Am J Med 107:27S?32S", "journal-title": "Am J Med"}, {"key": "CR2", "doi-asserted-by": "crossref", "first-page": "267", "DOI": "10.1007/s11938-002-0049-3", "volume": "5", "author": "JA Sach", "year": "2002", "unstructured": "Sach JA, Chang L (2002) Irritable bowel syndrome. Curr Treat Options Gastroenterol 5:267?278", "journal-title": "Curr Treat Options Gastroenterol"}, {"key": "CR3", "doi-asserted-by": "crossref", "first-page": "261", "DOI": "10.1007/s11938-001-0038-y", "volume": "4", "author": "R Fogel", "year": "2001", "unstructured": "Fogel R (2001) Fecal incontinence. Curr Treat Options Gastroenterol 4:261?266", "journal-title": "Curr Treat Options Gastroenterol"}, {"key": "CR4", "doi-asserted-by": "crossref", "first-page": "319", "DOI": "10.1007/s11938-003-0024-7", "volume": "6", "author": "LR Schiller", "year": "2003", "unstructured": "Schiller LR (2003) Treatment of fecal incontinence. Curr Treat Options Gastroenterol 6:319?327", "journal-title": "Curr Treat Options Gastroenterol"}, {"key": "CR5", "doi-asserted-by": "crossref", "first-page": "2787", "DOI": "10.1016/S0024-3205(02)02102-1", "volume": "71", "author": "DL Haven-Hudkins De", "year": "2002", "unstructured": "De Haven-Hudkins DL, Cowan A, Cortes Burgos L, Daubert JD, Cassel JA, DeHaven RN, Kehner GB, Kumar V, Park-Wyllie LY, Antoniou T (2002) Antipruritic and antihyperalgesic actions of loperamide and analogs. Life Sci 71:2787?2796", "journal-title": "Life Sci"}, {"key": "CR6", "first-page": "494", "volume": "289", "author": "DL Haven-Hudkins De", "year": "1999", "unstructured": "De Haven-Hudkins DL, Burgos LC, Cassel JA, Daubert JD, DeHaven RN, Mansson E, Nagasaka H, Yu G, Yaksh T (1999) Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J Pharmacol Exp Ther 289:494?502", "journal-title": "J Pharmacol Exp Ther"}, {"key": "CR7", "doi-asserted-by": "crossref", "first-page": "2517", "DOI": "10.1172/JCI118699", "volume": "97", "author": "AH Schinkel", "year": "1996", "unstructured": "Schinkel AH, Wagenaar E, Mol CA, van Deemter L (1996) P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 97:2517?2524", "journal-title": "J Clin Invest"}, {"key": "CR8", "doi-asserted-by": "crossref", "first-page": "231", "DOI": "10.1067/mcp.2000.109156", "volume": "68", "author": "AJ Sadeque", "year": "2000", "unstructured": "Sadeque AJ, Wandel C, He H, Shah S, Wood AJ (2000) Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther 68:231?237", "journal-title": "Clin Pharmacol Ther"}, {"key": "CR9", "doi-asserted-by": "crossref", "first-page": "205", "DOI": "10.1016/S0928-0987(00)00117-2", "volume": "12", "author": "A Eneroth", "year": "2001", "unstructured": "Eneroth A, Astrom E, Hoogstraate J, Schrenk D, Conrad S, Kauffmann HM, Gjellan K (2001) Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur J Pharm Sci 12:205?214", "journal-title": "Eur J Pharm Sci"}, {"key": "CR10", "doi-asserted-by": "crossref", "first-page": "913", "DOI": "10.1097/00000542-200204000-00019", "volume": "96", "author": "C Wandel", "year": "2002", "unstructured": "Wandel C, Kim R, Wood M, Wood A (2002) Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology 96:913?920", "journal-title": "Anesthesiology"}, {"key": "CR11", "doi-asserted-by": "crossref", "first-page": "199", "DOI": "10.1007/BF03189427", "volume": "4", "author": "H Miyazaki", "year": "1979", "unstructured": "Miyazaki H, Nambu K, Matsunaga Y, Hashimoto M (1979) Disposition and metabolism of [14C]loperamide in rats. Eur J Drug Metab Pharmacokinet. 4:199?206", "journal-title": "Eur J Drug Metab Pharmacokinet."}, {"key": "CR12", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1002/bms.1200060606", "volume": "6", "author": "K Yoshida", "year": "1979", "unstructured": "Yoshida K, Nambu K, Arakawa S, Miyazaki H, Hashimoto M (1979) Metabolites of loperamide in rats. Biomed Mass Spectrom 6:253?259", "journal-title": "Biomed Mass Spectrom"}, {"key": "CR13", "doi-asserted-by": "crossref", "first-page": "323", "DOI": "10.1016/S0378-4347(00)00253-X", "volume": "744", "author": "H He", "year": "2000", "unstructured": "He H, Sadeque A, Erve JC, Wood AJ, Hachey DL (2000) Quantitation of loperamide and N-demethyl-loperamide in human plasma using electrospray ionization with selected reaction ion monitoring liquid chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 744:323?331", "journal-title": "J Chromatogr B Biomed Sci Appl"}, {"key": "CR14", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1067/mcp.2001.119212", "volume": "70", "author": "Y Tayrouz", "year": "2001", "unstructured": "Tayrouz Y, Ganssmann B, Ding R, Klingmann A, Aderjan R, Burhenne J, Haefeli WE, Mikus G (2001) Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement. Clin Pharmacol Ther 70:405?414", "journal-title": "Clin Pharmacol Ther"}, {"key": "CR15", "doi-asserted-by": "crossref", "first-page": "3464", "DOI": "10.1128/AAC.47.11.3464-3469.2003", "volume": "47", "author": "JY Park", "year": "2003", "unstructured": "Park JY, Kim KA, Kim SL (2003) Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes. Antimicrob Agents Chemother 47:3464?3469", "journal-title": "Antimicrob Agents Chemother"}, {"key": "CR16", "doi-asserted-by": "crossref", "first-page": "1090", "DOI": "10.1124/dmd.31.9.1090", "volume": "31", "author": "KA Kim", "year": "2003", "unstructured": "Kim KA, Park JY (2003) Inhibitory effect of glyburide on human cytochrome p450 isoforms in human liver microsomes. Drug Metab Dispos 31:1090?1092", "journal-title": "Drug Metab Dispos"}, {"key": "CR17", "doi-asserted-by": "crossref", "first-page": "407", "DOI": "10.1007/s00228-003-0641-z", "volume": "59", "author": "JY Park", "year": "2003", "unstructured": "Park JY, Kim KA (2003) Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes. Eur J Clin Pharmacol 59:407?409", "journal-title": "Eur J Clin Pharmacol"}, {"key": "CR18", "doi-asserted-by": "crossref", "first-page": "107", "DOI": "10.1046/j.1365-2125.1998.00679.x", "volume": "45", "author": "VA Eagling", "year": "1998", "unstructured": "Eagling VA, Tjia JF, Back DJ (1998) Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes. Br J Clin Pharmacol 45:107?114", "journal-title": "Br J Clin Pharmacol"}, {"key": "CR19", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1016/0003-9861(92)90115-D", "volume": "298", "author": "R Pearce", "year": "1992", "unstructured": "Pearce R, Greenway D, Parkinson A (1992) Species differences and interindividual variation in liver microsomal cytochrome P4502A enzymes: effect on coumarin, dicumarol and testosterone oxidation. Arch Biochem Biophys 298:211?225", "journal-title": "Arch Biochem Biophys"}, {"key": "CR20", "first-page": "1429", "volume": "27", "author": "K Kobayashi", "year": "1999", "unstructured": "Kobayashi K, Abe S, Nakajima M, Shimada N, Tani M, Chiba K, Yamamoto T (1999) Role of human CYP2B6 in S-mephobarbital N-demethylation. Drug Metab Dispos 27:1429?1433", "journal-title": "Drug Metab Dispos"}, {"key": "CR21", "first-page": "5543", "volume": "54", "author": "A Rahman", "year": "1994", "unstructured": "Rahman A, Korzekwa KR, Grogan J, Gonzales FJ, Harris JW (1994) Selective biotransformation of Taxol to 6-alpha hydroxy Taxol by human cytochrome P450 2C8. Cancer Res 54:5543?5546", "journal-title": "Cancer Res"}, {"key": "CR22", "first-page": "154", "volume": "23", "author": "DJ Newton", "year": "1995", "unstructured": "Newton DJ, Wang RW, Lu AY (1995) Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 23:154?158", "journal-title": "Drug Metab Dispos"}, {"key": "CR23", "first-page": "853", "volume": "25", "author": "JW Ko", "year": "1997", "unstructured": "Ko JW, Sukhova N, Thacker D, Chen P, Flockhart DA (1997) Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms. Drug Metab Dispos 25:853?862", "journal-title": "Drug Metab Dispos"}, {"key": "CR24", "first-page": "1381", "volume": "27", "author": "M Nakajima", "year": "1999", "unstructured": "Nakajima M, Nakamura S, Tokudome S, Shimada N, Yamazaki H, Yokoi T (1999) Azelastine N-demethylation by cytochrome P-450 (CYP)3A4, CYP2D6, and CYP1A2 in human liver microsomes: evaluation of approach to predict the contribution of multiple CYPs. Drug Metab Dispos 27:1381?1391", "journal-title": "Drug Metab Dispos"}, {"key": "CR25", "first-page": "793", "volume": "295", "author": "E Stormer", "year": "2000", "unstructured": "Stormer E, von Moltke LL, Greenblatt DJ (2000) Scaling drug biotransformation data from cDNA-expressed cytochrome P-450 to human liver: a comparison of relative activity factors and human liver abundance in studies of mirtazapine metabolism. J Pharmacol Exp Ther 295:793?801", "journal-title": "J Pharmacol Exp Ther"}, {"key": "CR26", "first-page": "1493", "volume": "28", "author": "K Venkatakrishnan", "year": "2000", "unstructured": "Venkatakrishnan K, von Moltke LL, Court MH, Harmatz JS, Crespi CL, Greenblatt DJ (2000) Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches. Drug Metab Dispos 28:1493?1504", "journal-title": "Drug Metab Dispos"}, {"key": "CR27", "doi-asserted-by": "crossref", "first-page": "145", "DOI": "10.1124/dmd.31.1.145", "volume": "31", "author": "B Rochat", "year": "2003", "unstructured": "Rochat B (2003) Evaluation of recombinant cytochromes P450 activity in metabolic pathways. Drug Metab Dispos 31:145?146", "journal-title": "Drug Metab Dispos"}, {"key": "CR28", "first-page": "179", "volume": "26", "author": "CL Crespi", "year": "1995", "unstructured": "Crespi CL (1995) Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research. Adv Drug Res 26:179?235", "journal-title": "Adv Drug Res"}, {"key": "CR29", "doi-asserted-by": "crossref", "first-page": "1502", "DOI": "10.1021/js980255z", "volume": "87", "author": "K Venkatakrishnan", "year": "1998", "unstructured": "Venkatakrishnan K, von Moltke LL, Greenblatt DJ (1998) Human cytochromes P450 mediating phenacetin O-deethylation in vitro: validation of the high-affinity component as an index of CYP1A2 activity. J Pharm Sci 87:1502?1507", "journal-title": "J Pharm Sci"}, {"key": "CR30", "doi-asserted-by": "crossref", "first-page": "853", "DOI": "10.1124/dmd.30.7.853", "volume": "30", "author": "Y Hijazi", "year": "2002", "unstructured": "Hijazi Y, Boulieu R (2002) Contribution of CYP3A4, CYP2B6, and CYP2C9 isoforms to N-demethylation of ketamine in human liver microsomes. Drug Metab Dispos 30:853?858", "journal-title": "Drug Metab Dispos"}, {"key": "CR31", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1046/j.1365-2125.2001.00344.x", "volume": "51", "author": "Y Oda", "year": "2001", "unstructured": "Oda Y, Hamaoka N, Hiroi T, Imaoka S, Hase I, Tanaka K, Funae Y, Ishizaki T, Asada A (2001) Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. Br J Clin Pharmacol 51:281?285", "journal-title": "Br J Clin Pharmacol"}, {"key": "CR32", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1080/004982500237541", "volume": "30", "author": "Y Sai", "year": "2000", "unstructured": "Sai Y, Dai R, Yang TJ, Krausz KW, Gonzalez FJ, Gelboin HV, Shou M (2000) Assessment of specificity of eight chemical inhibitors using cDNA-expressed cytochromes P450. Xenobiotica 30:327?343", "journal-title": "Xenobiotica"}, {"key": "CR33", "first-page": "902", "volume": "27", "author": "GN Kumar", "year": "1999", "unstructured": "Kumar GN, Dykstra J, Roberts EM, Jayanti VK, Hickman D, Uchic J, Yao Y, Surber B, Thomas S, Granneman GR (1999) Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: a positive drug-drug interaction. Drug Metab Dispos 27:902?908", "journal-title": "Drug Metab Dispos"}, {"key": "CR34", "doi-asserted-by": "crossref", "first-page": "638", "DOI": "10.1097/00002030-200303070-00025", "volume": "17", "author": "LY Park-Wyllie", "year": "2003", "unstructured": "Park-Wyllie LY, Antoniou T (2003) Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series. AIDS 17:638?640", "journal-title": "AIDS"}, {"key": "CR35", "doi-asserted-by": "crossref", "first-page": "631", "DOI": "10.1007/BF02976712", "volume": "26", "author": "KA Kim", "year": "2003", "unstructured": "Kim KA, Park JY, Lee JS, Lim S (2003) Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes. Arch Pharm Res 26:631?637", "journal-title": "Arch Pharm Res"}, {"key": "CR36", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.1007/s002130000489", "volume": "151", "author": "E Stormer", "year": "2000", "unstructured": "Stormer E, Brockmoller J, Roots I, Schmider J (2000) Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro. Psychopharmacology 151:312?320", "journal-title": "Psychopharmacology"}], "container-title": ["European Journal of Clinical Pharmacology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00228-004-0815-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00228-004-0815-3/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00228-004-0815-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 24]], "date-time": "2019-05-24T12:41:34Z", "timestamp": 1558701694000}, "score": 35.05424, "issued": {"date-parts": [[2004, 9, 8]]}, "references-count": 36, "journal-issue": {"published-print": {"date-parts": [[2004, 10]]}, "issue": "8"}, "alternative-id": ["815"], "URL": "http://dx.doi.org/10.1007/s00228-004-0815-3", "relation": {"cites": []}, "ISSN": ["0031-6970", "1432-1041"], "issn-type": [{"value": "0031-6970", "type": "print"}, {"value": "1432-1041", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:36:57Z", "timestamp": 1574145417654}, "reference-count": 63, "publisher": "Elsevier BV", "issue": "12", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 12, 1]], "date-time": "1992-12-01T00:00:00Z", "timestamp": 723168000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical Pharmacology"], "published-print": {"date-parts": [[1992, 12]]}, "DOI": "10.1016/0006-2952(92)90674-8", "type": "journal-article", "created": {"date-parts": [[2002, 12, 13]], "date-time": "2002-12-13T22:04:39Z", "timestamp": 1039817079000}, "page": "2307-2314", "source": "Crossref", "is-referenced-by-count": 36, "title": ["The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes"], "prefix": "10.1016", "volume": "44", "author": [{"given": "Munir", "family": "Pirmohamed", "sequence": "first", "affiliation": []}, {"given": "Neil R.", "family": "Kitteringham", "sequence": "additional", "affiliation": []}, {"given": "Alasdair M.", "family": "Breckenridge", "sequence": "additional", "affiliation": []}, {"given": "B.Kevin", "family": "Park", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0006295292906748?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0006295292906748?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 8]], "date-time": "2019-02-08T00:13:59Z", "timestamp": 1549584839000}, "score": 32.883797, "issued": {"date-parts": [[1992, 12]]}, "references-count": 63, "journal-issue": {"published-print": {"date-parts": [[1992, 12]]}, "issue": "12"}, "alternative-id": ["0006295292906748"], "URL": "http://dx.doi.org/10.1016/0006-2952(92)90674-8", "ISSN": ["0006-2952"], "issn-type": [{"value": "0006-2952", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T08:06:48Z", "timestamp": 1575101208777}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "5-6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 9, 1]], "date-time": "2003-09-01T00:00:00Z", "timestamp": 1062374400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Clinical Pharmacology"], "published-print": {"date-parts": [[2003, 9, 1]]}, "DOI": "10.1007/s00228-003-0641-z", "type": "journal-article", "created": {"date-parts": [[2003, 10, 27]], "date-time": "2003-10-27T16:38:35Z", "timestamp": 1067272715000}, "page": "407-409", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Inhibitory effect of 5-fluorouracil on human cytochrome P 450 isoforms in human liver microsomes"], "prefix": "10.1007", "volume": "59", "author": [{"given": "Ji-Young", "family": "Park", "sequence": "first", "affiliation": []}, {"given": "Kyoung-Ah", "family": "Kim", "sequence": "additional", "affiliation": []}], "member": "297", "container-title": ["European Journal of Clinical Pharmacology"], "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s00228-003-0641-z.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s00228-003-0641-z/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s00228-003-0641-z", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 24]], "date-time": "2019-05-24T12:41:30Z", "timestamp": 1558701690000}, "score": 32.117012, "issued": {"date-parts": [[2003, 9, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2003, 9, 1]]}, "issue": "5-6"}, "alternative-id": ["8UELRT63382VQBLM"], "URL": "http://dx.doi.org/10.1007/s00228-003-0641-z", "ISSN": ["0031-6970", "1432-1041"], "issn-type": [{"value": "0031-6970", "type": "print"}, {"value": "1432-1041", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology", "General Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T21:50:24Z", "timestamp": 1574459424819}, "reference-count": 44, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1834, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2011, 8]]}, "DOI": "10.1111/j.1365-2710.2010.01201.x", "type": "journal-article", "created": {"date-parts": [[2010, 8, 29]], "date-time": "2010-08-29T17:00:26Z", "timestamp": 1283101226000}, "page": "496-503", "source": "Crossref", "is-referenced-by-count": 5, "title": ["In vitro inhibitory effects of Wen-pi-tang-Hab-Wu-ling-san on human cytochrome P450 isoforms"], "prefix": "10.1111", "volume": "36", "author": [{"given": "H. W.", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "D. W.", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "P. B.", "family": "Phapale", "sequence": "additional", "affiliation": []}, {"given": "M. -S.", "family": "Lim", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "J. J.", "family": "Seo", "sequence": "additional", "affiliation": []}, {"given": "K. M.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Y. -K.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Y. -R.", "family": "Yoon", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 8, 24]]}, "reference": [{"key": "10.1111/j.1365-2710.2010.01201.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "548", "DOI": "10.1002/ptr.2106", "article-title": "Wen-pi-tang-Hab-Wu-ling-san, an oriental herbal prescription, attenuates epithelial-mesenchymal transdifferentiation stimulated by TGF-\u03b21 in kidney cells", "volume": "21", "author": "Lee", "year": "2007", "journal-title": "Phytotherapy Research"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1142/S0192415X05003375", "article-title": "Activity of wen-pi-tang, and purified constituents of rhei rhizome and glycyrrhizae radix against glucose-mediated protein damage", "volume": "33", "author": "Nakagawa", "year": "2005", "journal-title": "American Journal of Chinese Medicine"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "439", "DOI": "10.1016/j.jep.2007.08.035", "article-title": "Wen-pi-tang-Hab-Wu-ling-san extract inhibits the release of inflammatory mediators from LPS-stimulated mouse macrophages", "volume": "114", "author": "Jung", "year": "2007", "journal-title": "Journal of Ethnopharmacology"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "1405", "DOI": "10.1211/0022357021783", "article-title": "Protection by the Chinese prescription Wen-Pi-Tang against renal tubular LLC-PK1 cell damage induced by 3-morpholinosydnonimine", "volume": "55", "author": "Yokozawa", "year": "2003", "journal-title": "Journal of Pharmacy and Pharmacology"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1057", "DOI": "10.1002/ptr.2440", "article-title": "Wen-pi-tang-Hab-Wu-ling-san attenuates kidney fibrosis induced by ischemia/reperfusion in mice", "volume": "22", "author": "Seok", "year": "2008", "journal-title": "Phytotherapy Research"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB6|cit6", "doi-asserted-by": "crossref", "first-page": "2046", "DOI": "10.1056/NEJMra020398", "article-title": "Herbal remedies", "volume": "347", "author": "De Smet", "year": "2002", "journal-title": "New England Journal of Medicine"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "526", "DOI": "10.2174/138920007781368863", "article-title": "Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update", "volume": "8", "author": "Zhou", "year": "2007", "journal-title": "Current Drug Metabolism"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "935", "DOI": "10.1016/j.lfs.2003.09.035", "article-title": "Herbal bioactivation: the good, the bad and the ugly", "volume": "74", "author": "Zhou", "year": "2004", "journal-title": "Life Sciences"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "23", "DOI": "10.1111/j.1742-7843.2007.00011.x", "article-title": "The induction of CYP1A2, CYP2D6, and CYP3A4 by six trade herbal products in cultured primary human hepatocytes", "volume": "100", "author": "Hellum", "year": "2007", "journal-title": "Basic & Clinical Pharmacology & Toxicology"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1513", "DOI": "10.2174/0929867043365198", "article-title": "Herb-drug interactions: an evidence based approach", "volume": "11", "author": "Coxeter", "year": "2004", "journal-title": "Current Medicinal Chemistry"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "1579", "DOI": "10.1016/S0024-3205(02)01913-6", "article-title": "Effects of herbal components on cDNA-expressed cytochrome P450 enzyme catalytic activity", "volume": "71", "author": "Zou", "year": "2002", "journal-title": "Life Sciences"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "525", "DOI": "10.1016/j.clpt.2003.08.009", "article-title": "The interaction between St John\u2019s wort and an oral contraceptive", "volume": "74", "author": "Hall", "year": "2003", "journal-title": "Clinical Pharmacology and Therapeutics"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "1239", "DOI": "10.2165/00003495-200565090-00005", "article-title": "Herb-drug interactions: a literature review", "volume": "65", "author": "Hu", "year": "2005", "journal-title": "Drugs"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "2211", "DOI": "10.1056/NEJMra032424", "article-title": "Drug metabolism and variability among patients in drug response", "volume": "352", "author": "Wilkinson", "year": "2005", "journal-title": "New England Journal of Medicine"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "35", "DOI": "10.1081/DMR-120018248", "article-title": "Interactions of herbs with cytochrome P450", "volume": "35", "author": "Zhou", "year": "2003", "journal-title": "Drug Metabolism Reviews"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "487", "DOI": "10.1126/science.286.5439.487", "article-title": "Pharmacogenomics: translating functional genomics into rational therapeutics", "volume": "286", "author": "Evans", "year": "1999", "journal-title": "Science"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "193", "DOI": "10.1016/j.tips.2004.02.007", "article-title": "Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future", "volume": "25", "author": "Ingelman-Sundberg", "year": "2004", "journal-title": "Trends in Pharmacological Sciences"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB18|cit18", "first-page": "387", "article-title": "Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver", "volume": "50", "author": "Ito", "year": "1998", "journal-title": "Pharmacological Reviews"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1016/j.jep.2007.03.015", "article-title": "Wen-pi-tang-Hab-Wu-ling-san attenuates kidney ischemia/reperfusion injury in mice. A role for antioxidant enzymes and heat-shock proteins", "volume": "112", "author": "Seok", "year": "2007", "journal-title": "Journal of Ethnopharmacology"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "1071", "DOI": "10.1023/A:1010994022294", "article-title": "Optimizing drug development: strategies to assess drug metabolism/transporter interaction potential - toward a consensus", "volume": "18", "author": "Tucker", "year": "2001", "journal-title": "Pharmaceutical Research"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "429", "DOI": "10.1080/00498250410001691253", "article-title": "Potential of pranlukast and zafirlukast in the inhibition of human liver cytochrome P450 enzymes", "volume": "34", "author": "Liu", "year": "2004", "journal-title": "Xenobiotica"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB22|cit22", "first-page": "1130", "article-title": "In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse", "volume": "25", "author": "Chauret", "year": "1997", "journal-title": "Drug Metabolism and Disposition"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1111/j.1365-2710.2006.00706.x", "article-title": "Inhibition of human cytochrome P450 isoforms and NADPH-CYP reductase in vitro by 15 herbal medicines, including Epimedii herba", "volume": "31", "author": "Liu", "year": "2006", "journal-title": "Journal of Clinical Pharmacy and Therapeutics"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "831", "DOI": "10.1016/j.jpba.2007.04.022", "article-title": "Analytical methodologies for the determination of omeprazole: an overview", "volume": "44", "author": "Bosch", "year": "2007", "journal-title": "Journal of Pharmaceutical and Biomedical Analysis"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB25|cit25", "doi-asserted-by": "crossref", "first-page": "112", "DOI": "10.1016/j.jchromb.2006.04.007", "article-title": "Determination of omeprazole in rat plasma by high-performance liquid chromatography without solvent extraction", "volume": "837", "author": "Jia", "year": "2006", "journal-title": "Journal of Chromatography, B: Analytical Technologies in the Biomedical and Life Sciences"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "338", "DOI": "10.1097/00007691-199308000-00013", "article-title": "Determination of midazolam and its [alpha]-hydroxy metabolite in human plasma and urine by high-performance liquid chromatography", "volume": "15", "author": "Ha", "year": "1993", "journal-title": "Therapeutic Drug Monitoring"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "361", "DOI": "10.1046/j.1365-2125.1998.t01-1-00692.x", "article-title": "Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalyzed by human CYP1A2", "volume": "45", "author": "Kobayashi", "year": "1998", "journal-title": "British Journal of Clinical Pharmacology"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "300", "DOI": "10.1097/00007691-199308000-00007", "article-title": "High-performance liquid chromatography determination of dextromethorphan and dextrorphan for oxidation phenotyping by fluorescence and ultraviolet detection", "volume": "15", "author": "Lam", "year": "1993", "journal-title": "Therapeutic Drug Monitoring"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "305", "DOI": "10.1016/0378-4347(94)00096-4", "article-title": "Determination of midazolam and two of its metabolites in human plasma by high-performance liquid chromatography", "volume": "655", "author": "Mastey", "year": "1994", "journal-title": "Journal of Chromatography. B, Biomedical Applications"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB30|cit30", "first-page": "38", "article-title": "Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system", "volume": "28", "author": "Palamanda", "year": "2000", "journal-title": "Drug Metabolism and Disposition"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1002/rcm.941", "article-title": "High-throughput cytochrome P450 inhibition assays by ultrafast gradient liquid chromatography with tandem mass spectrometry using monolithic columns", "volume": "17", "author": "Peng", "year": "2003", "journal-title": "Rapid Communications in Mass spectrometry"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1081/DMR-120001385", "article-title": "Introductory remarks on human CYPs", "volume": "34", "author": "Nelson", "year": "2002", "journal-title": "Drug Metabolism Reviews"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB33|cit33", "first-page": "1097", "article-title": "[O-Ethyl 14C] phenacetin O-deethylase activity in human liver microsomes", "volume": "25", "author": "Rodrigues", "year": "1997", "journal-title": "Drug Metabolism and Disposition"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "648", "DOI": "10.1124/dmd.30.6.648", "article-title": "Effect of albumin on phenytoin and tolbutamide metabolism in human liver microsomes: an impact more than protein binding", "volume": "30", "author": "Tang", "year": "2002", "journal-title": "Drug Metabolism and Disposition"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1124/jpet.302.1.43", "article-title": "Effect of albumin and cytosol on enzyme kinetics of tolbutamide hydroxylation and on inhibition of CYP2C9 by gemfibrozil in human liver microsomes", "volume": "302", "author": "Wang", "year": "2002", "journal-title": "Journal of Pharmacology and Experimental Therapeutics"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB36|cit36", "first-page": "52", "article-title": "Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4\u2032-hydroxylation", "volume": "266", "author": "Chiba", "year": "1993", "journal-title": "Journal of Pharmacology and Experimental Therapeutics"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1097/00008571-199308000-00004", "article-title": "CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans", "volume": "3", "author": "Jacqz-Aigrain", "year": "1993", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "243", "DOI": "10.1111/j.1365-2125.1994.tb04348.x", "article-title": "The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes", "volume": "38", "author": "Kerry", "year": "1994", "journal-title": "British Journal of Clinical Pharmacology"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "143", "DOI": "10.1097/00008571-199506000-00002", "article-title": "Chlorzoxazone is metabolized by human CYP1A2 as well as by human CYP2E1", "volume": "5", "author": "Ono", "year": "1995", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "1151", "DOI": "10.1016/S0006-2952(02)01226-1", "article-title": "Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes", "volume": "64", "author": "Lejus", "year": "2002", "journal-title": "Biochemical Pharmacology"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB41|cit41", "first-page": "940", "article-title": "Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cDNA-expressed human cytochrome P450", "volume": "24", "author": "Ghosal", "year": "1996", "journal-title": "Drug Metabolism and Disposition"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "157", "DOI": "10.1111/j.1600-0773.1999.tb00085.x", "article-title": "Midazolam a-hydroxylation by human liver microsomes in vitro: inhibition by calcium channel blockers, itraconazole and ketoconazole", "volume": "85", "author": "Wang", "year": "1999", "journal-title": "Pharmacology & Toxicology (Copenhagen)"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB43|cit43", "first-page": "23", "article-title": "A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450S using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry", "volume": "29", "author": "Dierks", "year": "2001", "journal-title": "Drug Metabolism and Disposition"}, {"key": "10.1111/j.1365-2710.2010.01201.x-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "2105", "DOI": "10.1016/j.lfs.2005.12.021", "article-title": "In vitro and in vivo assessment of herb drug interactions", "volume": "78", "author": "Venkataramanan", "year": "2006", "journal-title": "Life Science"}], "container-title": ["Journal of Clinical Pharmacy and Therapeutics"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2710.2010.01201.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 19]], "date-time": "2017-06-19T13:14:20Z", "timestamp": 1497878060000}, "score": 31.829773, "subtitle": ["Inhibition of cytochrome p450 by WHW"], "issued": {"date-parts": [[2010, 8, 24]]}, "references-count": 44, "journal-issue": {"published-print": {"date-parts": [[2011, 8]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1111/j.1365-2710.2010.01201.x", "relation": {"cites": []}, "ISSN": ["0269-4727"], "issn-type": [{"value": "0269-4727", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T05:31:34Z", "timestamp": 1575523894755}, "reference-count": 58, "publisher": "American Society for Pharmacology & Experimental Therapeutics (ASPET)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drug Metab Dispos"], "published-print": {"date-parts": [[2019, 12]]}, "DOI": "10.1124/dmd.119.087965", "type": "journal-article", "created": {"date-parts": [[2019, 10, 2]], "date-time": "2019-10-02T13:45:10Z", "timestamp": 1570023910000}, "page": "1372-1379", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Ginsenoside Rc Is a New Selective UGT1A9 Inhibitor in Human Liver Microsomes and Recombinant Human UGT Isoforms"], "prefix": "10.1124", "volume": "47", "author": [{"given": "Hyunyoung", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "Jae-Kyung", "family": "Heo", "sequence": "additional", "affiliation": []}, {"given": "Ga-Hyun", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "So-Young", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Su-Nyeong", "family": "Jang", "sequence": "additional", "affiliation": []}, {"given": "Hyun-Ji", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Mi Jeong", "family": "Kwon", "sequence": "additional", "affiliation": []}, {"given": "Im-Sook", "family": "Song", "sequence": "additional", "affiliation": []}, {"given": "Kwang-Hyeon", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "36", "published-online": {"date-parts": [[2019, 10, 2]]}, "reference": [{"key": "2019110712551329000_47.12.1372.1", "DOI": "10.1124/dmd.112.047878", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.2", "DOI": "10.1016/S0006-2952(99)00212-9", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.3", "DOI": "10.2337/diabetes.51.6.1851", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.4", "DOI": "10.1345/aph.1E508", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.5", "DOI": "10.1345/aph.1M715", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.6", "DOI": "10.1124/dmd.31.7.815", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.7", "DOI": "10.1111/j.1745-7254.2008.00868.x", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.8", "DOI": "10.1016/j.ijcard.2004.07.022", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.9", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.1016/j.fct.2014.06.020", "article-title": "Evaluation of the in vitro/in vivo potential of five berries (bilberry, blueberry, cranberry, elderberry, and raspberry ketones) commonly used as herbal supplements to inhibit uridine diphospho-glucuronosyltransferase", "volume": "72", "author": "Choi", "year": "2014", "journal-title": "Food Chem Toxicol"}, {"key": "2019110712551329000_47.12.1372.10", "unstructured": "Choi MK Jin S Jeon JH Kang WY Seong SJ Yoon YR Han YH Song IS (2019) Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings. J Ginseng Res DOI: 10.1016/j.jgr.2018.1010.1006."}, {"key": "2019110712551329000_47.12.1372.11", "doi-asserted-by": "crossref", "first-page": "75", "DOI": "10.1016/j.jchromb.2012.12.022", "article-title": "Determination of ginsenoside Rc in rat plasma by LC-MS/MS and its application to a pharmacokinetic study", "volume": "919\u2013920", "author": "Chu", "year": "2013", "journal-title": "J Chromatogr B Analyt Technol Biomed Life Sci"}, {"key": "2019110712551329000_47.12.1372.12", "DOI": "10.1016/S0076-6879(05)00007-8", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.13", "DOI": "10.1016/j.taap.2012.12.019", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.14", "DOI": "10.1016/j.bcp.2007.01.030", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.15", "doi-asserted-by": "crossref", "first-page": "100", "DOI": "10.1016/j.jchromb.2007.11.009", "article-title": "Development of a liquid chromatography-tandem mass spectrometry method for the determination of 23 endogenous steroids in small quantities of primate urine", "volume": "862", "author": "Hauser", "year": "2008", "journal-title": "J Chromatogr B Analyt Technol Biomed Life Sci"}, {"key": "2019110712551329000_47.12.1372.16", "DOI": "10.1007/s002280000252", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.17", "doi-asserted-by": "crossref", "first-page": "331", "DOI": "10.1007/s11655-015-2146-x", "article-title": "Adjuvant effects of fermented red ginseng extract on advanced non-small cell lung cancer patients treated with chemotherapy", "volume": "23", "author": "Jiang", "year": "2017", "journal-title": "Chin J Integr Med"}, {"key": "2019110712551329000_47.12.1372.18", "unstructured": "Jin S Jeon JH Lee S Kang WY Seong SJ Yoon YR Choi MK Song IS (2019) Detection of 13 ginsenosides (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1, Rg3, Rh2, F1, compound K, 20(S)-Protopanaxadiol, and 20(S)-Protopanaxatriol) in human plasma and application of the analytical method to human pharmacokinetic studies following two week-repeated administration of red ginseng extract. Molecules 24.", "DOI": "10.3390/molecules24142618", "doi-asserted-by": "crossref"}, {"key": "2019110712551329000_47.12.1372.19", "DOI": "10.1002/rcm.7030", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.20", "doi-asserted-by": "crossref", "first-page": "389", "DOI": "10.3746/pnf.2016.21.4.389", "article-title": "Comparison of ginsenoside contents in different parts of Korean ginseng (Panax ginseng C.A. Meyer)", "volume": "21", "author": "Kang", "year": "2016", "journal-title": "Prev Nutr Food Sci"}, {"key": "2019110712551329000_47.12.1372.21", "DOI": "10.1111/dom.12024", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.22", "doi-asserted-by": "crossref", "first-page": "809", "DOI": "10.1248/jhs.55.809", "article-title": "Ginseng extracts facilitate cytochrome P450 xenobiotic metabolism in primary cultures of rat hepatocytes", "volume": "55", "author": "Kawase", "year": "2009", "journal-title": "J Health Sci"}, {"key": "2019110712551329000_47.12.1372.23", "DOI": "10.1016/j.pharmthera.2004.10.013", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.24", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.toxlet.2016.07.108", "article-title": "In vitro stereoselective inhibition of ginsenosides toward UDP-glucuronosyltransferase (UGT) isoforms", "volume": "259", "author": "Kim", "year": "2016", "journal-title": "Toxicol Lett"}, {"key": "2019110712551329000_47.12.1372.25", "unstructured": "Kim HS Kim MK Lee M Kwon BS Suh DH Song YS (2017) Effect of red ginseng on genotoxicity and health-related quality of life after adjuvant chemotherapy in patients with epithelial ovarian cancer: a randomized, double blind, placebo-controlled trial. Nutrients 9.", "DOI": "10.3390/nu9070772", "doi-asserted-by": "crossref"}, {"key": "2019110712551329000_47.12.1372.26", "doi-asserted-by": "crossref", "first-page": "370", "DOI": "10.1016/j.jgr.2017.08.008", "article-title": "Effect of Korean Red Ginseng extracts on drug-drug interactions", "volume": "42", "author": "Kim", "year": "2018", "journal-title": "J Ginseng Res"}, {"key": "2019110712551329000_47.12.1372.27", "DOI": "10.1016/j.jgr.2014.03.001", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.28", "doi-asserted-by": "crossref", "first-page": "771", "DOI": "10.1016/j.jep.2009.11.022", "article-title": "Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism", "volume": "127", "author": "Lee", "year": "2010", "journal-title": "J Ethnopharmacol"}, {"key": "2019110712551329000_47.12.1372.29", "doi-asserted-by": "crossref", "first-page": "384", "DOI": "10.1016/j.jgr.2015.04.009", "article-title": "Characterization of Korean Red Ginseng (Panax ginseng Meyer): history, preparation method, and chemical composition", "volume": "39", "author": "Lee", "year": "2015", "journal-title": "J Ginseng Res"}, {"key": "2019110712551329000_47.12.1372.30", "doi-asserted-by": "crossref", "first-page": "2052", "DOI": "10.1248/bpb.b16-00581", "article-title": "Inhibitory effect of hesperetin and naringenin on human UDP-glucuronosyltransferase enzymes: implications for herb-drug interactions", "volume": "39", "author": "Liu", "year": "2016", "journal-title": "Biol Pharm Bull"}, {"key": "2019110712551329000_47.12.1372.31", "DOI": "10.1177/0091270011407194", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.32", "doi-asserted-by": "crossref", "first-page": "355", "DOI": "10.1002/jcph.595", "article-title": "Assessment of pharmacokinetic drug-drug interaction between pradigastat and atazanavir or probenecid", "volume": "56", "author": "Mendonza", "year": "2016", "journal-title": "J Clin Pharmacol"}, {"key": "2019110712551329000_47.12.1372.33", "DOI": "10.1124/dmd.110.037036", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.34", "DOI": "10.1124/dmd.111.039602", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.35", "author": "Mroz", "volume": "70", "first-page": "972", "year": "2018", "volume-title": "Pharmacol Rep"}, {"key": "2019110712551329000_47.12.1372.36", "DOI": "10.1271/bbb.80525", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.37", "DOI": "10.1124/dmd.114.062141", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.38", "DOI": "10.1124/dmd.32.2.235", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.39", "DOI": "10.1124/dmd.115.065870", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.40", "DOI": "10.1158/1078-0432.CCR-11-2484", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.41", "DOI": "10.1124/dmd.117.075036", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.42", "DOI": "10.1016/j.phytochem.2011.02.012", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.43", "DOI": "10.1093/infdis/169.5.1103", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.44", "DOI": "10.1124/dmd.114.058818", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.45", "doi-asserted-by": "crossref", "first-page": "1322", "DOI": "10.1016/j.clinthera.2018.06.017", "article-title": "A comprehensive in vivo and in vitro assessment of the drug interaction potential of red ginseng", "volume": "40", "author": "Seong", "year": "2018", "journal-title": "Clin Ther"}, {"key": "2019110712551329000_47.12.1372.46", "first-page": "86", "article-title": "An open trial of nifedipine-herb interactions: nifedipine with St. John\u2019s wort, ginseng, or Ginkgo biloba", "volume": "69", "author": "Smith", "year": "2001", "journal-title": "Clin Pharmacol Ther"}, {"key": "2019110712551329000_47.12.1372.47", "DOI": "10.1124/dmd.32.1.140", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.48", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1111/jphp.12014", "article-title": "Glucuronidation of the broad-spectrum antiviral drug arbidol by UGT isoforms", "volume": "65", "author": "Song", "year": "2013", "journal-title": "J Pharm Pharmacol"}, {"key": "2019110712551329000_47.12.1372.49", "DOI": "10.1016/j.steroids.2009.07.004", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.50", "DOI": "10.1124/dmd.109.029231", "doi-asserted-by": "publisher"}, {"issue": "4A", "key": "2019110712551329000_47.12.1372.51", "doi-asserted-by": "crossref", "first-page": "447", "DOI": "10.1017/S1368980000000525", "article-title": "Herbal medicine: from the past to the future", "volume": "3", "author": "Tyler", "year": "2000", "journal-title": "Public Health Nutr"}, {"key": "2019110712551329000_47.12.1372.52", "DOI": "10.1124/dmd.105.007369", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.53", "DOI": "10.1124/dmd.32.4.413", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.54", "DOI": "10.1345/aph.10031", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.55", "doi-asserted-by": "crossref", "first-page": "756", "DOI": "10.1631/jzus.2007.B0756", "article-title": "Stereoselective glucuronidation of carvedilol by Chinese liver microsomes", "volume": "8", "author": "You", "year": "2007", "journal-title": "J Zhejiang Univ Sci B"}, {"key": "2019110712551329000_47.12.1372.56", "DOI": "10.1124/dmd.105.005447", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.57", "DOI": "10.1016/j.fct.2014.03.004", "doi-asserted-by": "publisher"}, {"key": "2019110712551329000_47.12.1372.58", "doi-asserted-by": "crossref", "first-page": "1001", "DOI": "10.3109/00498254.2012.681814", "article-title": "Potent and selective inhibition of magnolol on catalytic activities of UGT1A7 and 1A9", "volume": "42", "author": "Zhu", "year": "2012", "journal-title": "Xenobiotica"}], "container-title": ["Drug Metabolism and Disposition"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1124/dmd.119.087965", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 7]], "date-time": "2019-11-07T20:55:33Z", "timestamp": 1573160133000}, "score": 28.379593, "issued": {"date-parts": [[2019, 10, 2]]}, "references-count": 58, "journal-issue": {"published-online": {"date-parts": [[2019, 11, 7]]}, "published-print": {"date-parts": [[2019, 12]]}, "issue": "12"}, "alternative-id": ["10.1124/dmd.119.087965"], "URL": "http://dx.doi.org/10.1124/dmd.119.087965", "relation": {"cites": []}, "ISSN": ["0090-9556", "1521-009X"], "issn-type": [{"value": "0090-9556", "type": "print"}, {"value": "1521-009X", "type": "electronic"}], "subject": ["Pharmacology", "Pharmaceutical Science"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T15:29:57Z", "timestamp": 1575214197803}, "reference-count": 5, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2018, 3, 1]], "date-time": "2018-03-01T00:00:00Z", "timestamp": 1519862400000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/", "start": {"date-parts": [[2017, 12, 21]], "date-time": "2017-12-21T00:00:00Z", "timestamp": 1513814400000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"DOI": "10.13039/501100001321", "name": "National Research Foundation", "doi-asserted-by": "publisher", "award": ["2017M3A9B4042581"]}], "content-domain": {"domain": ["elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Stem Cell Research"], "published-print": {"date-parts": [[2018, 3]]}, "DOI": "10.1016/j.scr.2017.12.014", "type": "journal-article", "created": {"date-parts": [[2017, 12, 23]], "date-time": "2017-12-23T19:26:58Z", "timestamp": 1514057218000}, "page": "34-37", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Human induced pluripotent stem cell line with cytochrome P450 enzyme polymorphism (CYP2C19*2/CYP3A5*3C) generated from lymphoblastoid cells"], "prefix": "10.1016", "volume": "27", "author": [{"ORCID": "http://orcid.org/0000-0001-6962-0628", "authenticated-orcid": false, "given": "Jaehun", "family": "Lee", "sequence": "first", "affiliation": []}, {"given": "Dong-Hun", "family": "Woo", "sequence": "additional", "affiliation": []}, {"given": "Han-Jin", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Kijung", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Duck Sung", "family": "Ko", "sequence": "additional", "affiliation": []}, {"given": "Jong-Hoon", "family": "Kim", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Stem Cell Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1873506117302738?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1873506117302738?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 8, 25]], "date-time": "2018-08-25T03:32:38Z", "timestamp": 1535167958000}, "score": 27.79344, "issued": {"date-parts": [[2018, 3]]}, "references-count": 5, "alternative-id": ["S1873506117302738"], "URL": "http://dx.doi.org/10.1016/j.scr.2017.12.014", "ISSN": ["1873-5061"], "issn-type": [{"value": "1873-5061", "type": "print"}], "subject": ["Developmental Biology", "Cell Biology", "General Medicine"], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "Human induced pluripotent stem cell line with cytochrome P450 enzyme polymorphism (CYP2C19*2/CYP3A5*3C) generated from lymphoblastoid cells", "name": "articletitle", "label": "Article Title"}, {"value": "Stem Cell Research", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.scr.2017.12.014", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2018 The Authors. Published by Elsevier B.V.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:01:37Z", "timestamp": 1574114497059}, "reference-count": 41, "publisher": "Elsevier BV", "issue": "22", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 4, 1]], "date-time": "2004-04-01T00:00:00Z", "timestamp": 1080777600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Life Sciences"], "published-print": {"date-parts": [[2004, 4]]}, "DOI": "10.1016/j.lfs.2003.10.020", "type": "journal-article", "created": {"date-parts": [[2004, 3, 6]], "date-time": "2004-03-06T11:41:51Z", "timestamp": 1078573311000}, "page": "2769-2779", "source": "Crossref", "is-referenced-by-count": 78, "title": ["Inhibition of cytochrome P450 activities by oleanolic acid and ursolic acid in human liver microsomes"], "prefix": "10.1016", "volume": "74", "author": [{"given": "Kyoung-Ah", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Ji-Suk", "family": "Lee", "sequence": "additional", "affiliation": []}, {"given": "Hi-Joon", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Jin-Woo", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Chang-Ju", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "In-Sop", "family": "Shim", "sequence": "additional", "affiliation": []}, {"given": "Nam-Jae", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Seung-Moo", "family": "Han", "sequence": "additional", "affiliation": []}, {"given": "Sabina", "family": "Lim", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Life Sciences"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0024320504000876?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0024320504000876?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T19:27:41Z", "timestamp": 1550172461000}, "score": 27.712036, "issued": {"date-parts": [[2004, 4]]}, "references-count": 41, "journal-issue": {"published-print": {"date-parts": [[2004, 4]]}, "issue": "22"}, "alternative-id": ["S0024320504000876"], "URL": "http://dx.doi.org/10.1016/j.lfs.2003.10.020", "ISSN": ["0024-3205"], "issn-type": [{"value": "0024-3205", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T18:08:37Z", "timestamp": 1574532517999}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[1996, 12, 1]], "date-time": "1996-12-01T00:00:00Z", "timestamp": 849398400000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Exp Mol Med"], "published-print": {"date-parts": [[1996, 12]]}, "DOI": "10.1038/emm.1996.26", "type": "journal-article", "created": {"date-parts": [[2013, 1, 28]], "date-time": "2013-01-28T11:19:41Z", "timestamp": 1359371981000}, "page": "167-172", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Diallyl sulfide down-regulates polycyclic aromatic hydrocarbon-induced cytochrome P450 1A1 in mouse liver and lung"], "prefix": "10.1038", "volume": "28", "author": [{"given": "Young-Sook", "family": "Hong", "sequence": "first", "affiliation": []}, {"given": "Hae-Young", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Sang-Shin", "family": "Park", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[1996, 12, 1]]}, "container-title": ["Experimental & Molecular Medicine"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/emm199626.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/emm199626", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/emm199626.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T01:47:21Z", "timestamp": 1552787241000}, "score": 26.31464, "issued": {"date-parts": [[1996, 12]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1996, 12]]}, "issue": "4"}, "alternative-id": ["BFemm199626"], "URL": "http://dx.doi.org/10.1038/emm.1996.26", "ISSN": ["2092-6413"], "issn-type": [{"value": "2092-6413", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:36:53Z", "timestamp": 1574145413089}, "reference-count": 27, "publisher": "Elsevier BV", "issue": "5", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1993, 3, 1]], "date-time": "1993-03-01T00:00:00Z", "timestamp": 730944000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical Pharmacology"], "published-print": {"date-parts": [[1993, 3]]}, "DOI": "10.1016/0006-2952(93)90252-r", "type": "journal-article", "created": {"date-parts": [[2002, 12, 13]], "date-time": "2002-12-13T22:04:39Z", "timestamp": 1039817079000}, "page": "1079-1085", "source": "Crossref", "is-referenced-by-count": 52, "title": ["Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene and trichloroethylene in liver microsomes"], "prefix": "10.1016", "volume": "45", "author": [{"given": "Nakajima", "family": "Tamie", "sequence": "first", "affiliation": []}, {"given": "Wang", "family": "Rui-Sheng", "sequence": "additional", "affiliation": []}, {"given": "Eivor", "family": "Elovaara", "sequence": "additional", "affiliation": []}, {"given": "Sang S.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Harry V.", "family": "Gelboin", "sequence": "additional", "affiliation": []}, {"given": "Harri", "family": "Vainio", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:000629529390252R?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:000629529390252R?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 8]], "date-time": "2019-02-08T00:15:41Z", "timestamp": 1549584941000}, "score": 26.00531, "issued": {"date-parts": [[1993, 3]]}, "references-count": 27, "journal-issue": {"published-print": {"date-parts": [[1993, 3]]}, "issue": "5"}, "alternative-id": ["000629529390252R"], "URL": "http://dx.doi.org/10.1016/0006-2952(93)90252-r", "ISSN": ["0006-2952"], "issn-type": [{"value": "0006-2952", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:03:58Z", "timestamp": 1574269438864}, "reference-count": 0, "publisher": "Georg Thieme Verlag KG", "issue": "05", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Planta Med"], "published-print": {"date-parts": [[1997, 10]]}, "DOI": "10.1055/s-2006-957724", "type": "journal-article", "created": {"date-parts": [[2007, 1, 25]], "date-time": "2007-01-25T08:27:07Z", "timestamp": 1169713627000}, "page": "415-418", "source": "Crossref", "is-referenced-by-count": 53, "title": ["Protection of Rat Liver Microsomes against Carbon Tetrachloride-Induced Lipid Peroxidation by Red Ginseng Saponin through Cytochrome P450 Inhibition"], "prefix": "10.1055", "volume": "63", "author": [{"given": "Hyun", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "Young", "family": "Chun", "sequence": "additional", "affiliation": []}, {"given": "Jong", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "Shin", "family": "Kim", "sequence": "additional", "affiliation": []}, {"given": "Jung", "family": "Roh", "sequence": "additional", "affiliation": []}, {"given": "Tae", "family": "Jeong", "sequence": "additional", "affiliation": []}], "member": "194", "published-online": {"date-parts": [[2007, 1, 4]]}, "container-title": ["Planta Medica"], "language": "en", "link": [{"URL": "http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2006-957724.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 5, 22]], "date-time": "2017-05-22T21:27:27Z", "timestamp": 1495488447000}, "score": 26.00531, "issued": {"date-parts": [[1997, 10]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1997, 10]]}, "issue": "05"}, "URL": "http://dx.doi.org/10.1055/s-2006-957724", "ISSN": ["0032-0943", "1439-0221"], "issn-type": [{"value": "0032-0943", "type": "print"}, {"value": "1439-0221", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:16:57Z", "timestamp": 1574486217010}, "reference-count": 45, "publisher": "Wiley", "issue": "4", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 7275, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["British Journal of Clinical Pharmacology"], "published-print": {"date-parts": [[1995, 10]]}, "DOI": "10.1111/j.1365-2125.1995.tb04559.x", "type": "journal-article", "created": {"date-parts": [[2012, 7, 5]], "date-time": "2012-07-05T05:54:32Z", "timestamp": 1341467672000}, "page": "369-378", "source": "Crossref", "is-referenced-by-count": 39, "title": ["An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems."], "prefix": "10.1111", "volume": "40", "author": [{"given": "RC", "family": "Halliday", "sequence": "first", "affiliation": []}, {"given": "BC", "family": "Jones", "sequence": "additional", "affiliation": []}, {"given": "DA", "family": "Smith", "sequence": "additional", "affiliation": []}, {"given": "NR", "family": "Kitteringham", "sequence": "additional", "affiliation": []}, {"given": "BK", "family": "Park", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 7, 4]]}, "reference": [{"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB1|cit2", "doi-asserted-by": "crossref", "first-page": "1075", "DOI": "10.4269/ajtmh.1982.31.1075", "article-title": "Evaluation of antimalarial activity of the phenanthrene methanol halofantrine", "volume": "31", "author": "Cosgriff", "year": "1982", "journal-title": "Am J Trop Med Hyg"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB2|cit3", "doi-asserted-by": "crossref", "first-page": "501", "DOI": "10.1016/0140-6736(93)91631-U", "article-title": "Cardiac effects of halofantrine", "volume": "342", "author": "Karbwang", "year": "1993", "journal-title": "Lancet"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB3|cit4", "doi-asserted-by": "crossref", "first-page": "1054", "DOI": "10.1016/0140-6736(93)92412-M", "article-title": "Cardiac effects of antimalarial treatment with halofantrine", "volume": "341", "author": "Nosten", "year": "1993", "journal-title": "Lancet"}, {"issue": "suppl", "key": "10.1111/j.1365-2125.1995.tb04559.x-BIB4|cit5", "doi-asserted-by": "crossref", "first-page": "15", "DOI": "10.1016/S0169-4758(89)80004-3", "article-title": "Human pharmacokinetics of halofantrine hydrochloride", "author": "Broom", "year": "1989", "journal-title": "Parasitology Today"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB5|cit6", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1016/S0378-4347(00)80618-0", "article-title": "Determination of halofantrine and its principal metabolite desbutylhalofantrine in biological fluids by reverse-phase highperformance liquid chromatography", "volume": "433", "author": "Milton", "year": "1988", "journal-title": "J Chromatogr"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB6|cit7", "doi-asserted-by": "crossref", "first-page": "236", "DOI": "10.2165/00003495-199243020-00009", "article-title": "Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential", "volume": "43", "author": "Bryson", "year": "1992", "journal-title": "Drugs"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB7|cit8", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.1038/clpt.1991.131", "article-title": "Molecular genetics of the debrisoquine-sparteine polymorphism", "volume": "50", "author": "Gonzalez", "year": "1991", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB8|cit9", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1111/j.1365-2125.1993.tb05681.x", "article-title": "Molecular heterogeneity of the XbaI defined 44 kb allele of the CYP2D6 locus within the Caucasian population", "volume": "35", "author": "Mura", "year": "1993", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB9|cit10", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1097/00008571-199310000-00005", "article-title": "Evidence for a new variant CYP2D6J in a Japanese population associated with lower in vivo rates of sparteine metabolism", "volume": "3", "author": "Yokota", "year": "1993", "journal-title": "Pharmacogenetics"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB10|cit11", "first-page": "17209", "article-title": "Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine", "volume": "265", "author": "Kagimoto", "year": "1990", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB11|cit12", "doi-asserted-by": "crossref", "first-page": "211", "DOI": "10.1021/tx00026a010", "article-title": "A predictive model for substrates of cytochrome P450debrisoquine (2D6)", "volume": "5", "author": "Koymans", "year": "1992", "journal-title": "Chem Res Toxicol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB12|cit13", "doi-asserted-by": "crossref", "first-page": "1136", "DOI": "10.1021/jm00061a004", "article-title": "Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: Molecular modelling and inhibition studies", "volume": "36", "author": "Strobl", "year": "1993", "journal-title": "J Med Chem"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB13|cit14", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1007/BF00125503", "article-title": "A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building", "volume": "7", "author": "Koymans", "year": "1993", "journal-title": "J Comput-Aided Mol Design"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB14|cit15", "doi-asserted-by": "crossref", "first-page": "20892098", "DOI": "10.1016/0006-2952(92)90333-E", "article-title": "Speculations on the substrate structure-activity relationships (SSAR) of cytochrome P450 enzymes", "volume": "44", "author": "Smith", "year": "1992", "journal-title": "Biochem Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB15|cit16", "author": "Gentest", "year": "19911992", "volume-title": "Gentest Corporation Catalog"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB16|cit17", "doi-asserted-by": "crossref", "first-page": "1375", "DOI": "10.1016/0140-6736(92)91196-F", "article-title": "Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease", "volume": "339", "author": "Smith", "year": "1992", "journal-title": "Lancet"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB17|cit18", "doi-asserted-by": "crossref", "first-page": "281", "DOI": "10.1016/0022-4731(90)90285-Z", "article-title": "Metabolism of the contraceptive steroid desgestrel by human liver in vitro", "volume": "35", "author": "Madden", "year": "1990", "journal-title": "J Steroid Biochem"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB18|cit19", "first-page": "2370", "article-title": "The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein nature", "volume": "239", "author": "Omura", "year": "1964", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB19|cit20", "first-page": "265", "article-title": "Protein measurement with the folin phenol reagent", "volume": "193", "author": "Lowry", "year": "1951", "journal-title": "J Biol Chem"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB20|cit21", "doi-asserted-by": "crossref", "first-page": "24", "DOI": "10.1016/0003-2697(87)90006-6", "article-title": "High-performance liquid chromatography assays for bufuralol 1\u2032-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan 0-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver", "volume": "162", "author": "Kronbach", "year": "1987", "journal-title": "Anal Biochem"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB21|cit22", "author": "Spaldin", "year": "1995", "article-title": "Determination of human hepatic cytochrome P450 1A2 activity in vitro-use of tacrine as an isoenzyme specific probe", "journal-title": "Drug Metab Dispos"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB22|cit23", "doi-asserted-by": "crossref", "first-page": "649", "DOI": "10.1021/tx00035a009", "article-title": "Isoform-selective mechanismbased inhibition of cytochrome P450 1A2 by furafylline", "volume": "6", "author": "Kunze", "year": "1993", "journal-title": "Chem Res Toxicol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB23|cit24", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1016/0378-4347(92)80461-X", "article-title": "Measurement of halofantrine and its major metabolite desbutylhalofantrine in plasma and blood by high-performance liquid chromatography: a new methodology", "volume": "581", "author": "Mberu", "year": "1992", "journal-title": "J Chromatogr"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB24|cit25", "doi-asserted-by": "crossref", "first-page": "680", "DOI": "10.1038/227680a0", "article-title": "Cleavage of structural proteins during the assembly of the head of bacteriophage T4", "volume": "227", "author": "Laemmli", "year": "1970", "journal-title": "Nature"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB25|cit26", "doi-asserted-by": "crossref", "first-page": "313", "DOI": "10.1016/0022-1759(84)90001-2", "article-title": "Immunoblotting and dot immunobinding-current status and outlook", "volume": "72", "author": "Towbin", "year": "1984", "journal-title": "J Immunol Meth"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB26|cit27", "author": "Hyland", "article-title": "Production of a human CYP3A antibody from multiple peptide sequences", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB27|cit28", "doi-asserted-by": "crossref", "first-page": "1838", "DOI": "10.1021/jm00110a012", "article-title": "Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P450 IIIA4", "volume": "34", "author": "Guengerich", "year": "1991", "journal-title": "J Med Chem"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB28|cit29", "doi-asserted-by": "crossref", "first-page": "509", "DOI": "10.1016/0076-6879(91)06120-R", "article-title": "Bufuralol, dextromethorphan and debrisoquine as prototype substrates for human P4501ID6", "volume": "206", "author": "Kronbach", "year": "1991", "journal-title": "Methods Enzymol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB29|cit30", "first-page": "568", "article-title": "Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes", "volume": "46", "author": "Yamazaki", "year": "1994", "journal-title": "Mol Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB30|cit31", "doi-asserted-by": "crossref", "first-page": "73", "DOI": "10.1016/0024-3205(84)90332-1", "article-title": "Competitive inhibition of sparteine oxidation in human liver J-adrenoceptor antagonists and other cardiovascular drugs", "volume": "34", "author": "Otton", "year": "1984", "journal-title": "Life Sci"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB31|cit32", "doi-asserted-by": "crossref", "first-page": "561", "DOI": "10.1007/BF00196116", "article-title": "Plasma concentrations of the enantiomers of halofantrine and its main metabolite in malaria patients", "volume": "46", "author": "Gimenez", "year": "1994", "journal-title": "Eur J Clin Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB32|cit33", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1111/j.1365-2125.1992.tb04081.x", "article-title": "In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum", "volume": "33", "author": "Basco", "year": "1992", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB33|cit34", "doi-asserted-by": "crossref", "first-page": "163", "DOI": "10.1006/taap.1994.1061", "article-title": "Contemporary issues in toxicology. Selective inhibitors of cytochrome P450", "volume": "125", "author": "Halpert", "year": "1994", "journal-title": "Toxicol Appl Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB34|cit35", "first-page": "414", "article-title": "Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with human liver microsomes of 30 Japanese and 30 Caucasians", "volume": "270", "author": "Shimada", "year": "1994", "journal-title": "J Pharmacol Exp Ther"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB35|cit36", "doi-asserted-by": "crossref", "first-page": "1289", "DOI": "10.3109/00498259309059439", "article-title": "Analysis of imipramine and three metabolites produced by isozyme CYP2D6 expressed in a human cell line", "volume": "23", "author": "Su", "year": "1993", "journal-title": "Xenobiotica"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB36|cit37", "doi-asserted-by": "crossref", "first-page": "312", "DOI": "10.1111/j.1600-0773.1987.tb01758.x", "article-title": "Extensive metabolisers of debrisoquine become poor metabolisers during quinidine treatment", "volume": "60", "author": "Brosen", "year": "1987", "journal-title": "Pharmacol Tox"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB37|cit38", "doi-asserted-by": "crossref", "first-page": "299", "DOI": "10.1111/j.1365-2125.1990.tb03639.x", "article-title": "A dose effect study of the in vivo inhibitory effect of quinidine on sparteine oxidation in man", "volume": "29", "author": "Nielsen", "year": "1990", "journal-title": "Br J Clin Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB38|cit39", "doi-asserted-by": "crossref", "first-page": "349", "DOI": "10.1007/BF00316471", "article-title": "Inhibition by paroxetine of desipramine metabolism in extensive but not poor metabolisers of sparteine", "volume": "44", "author": "Brosen", "year": "1993", "journal-title": "Eur J Glin Pharmacol"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB39|cit40", "doi-asserted-by": "crossref", "first-page": "1002", "DOI": "10.1007/BF00180032", "article-title": "The pharmacokinetics of the selective serotonin reuptake inhibitors", "volume": "71", "author": "Brosen", "year": "1993", "journal-title": "Clin Invest"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB40|cit41", "doi-asserted-by": "crossref", "first-page": "59", "DOI": "10.2165/00003088-199426010-00005", "article-title": "Pharmacogenetic phenotyping and genotyping", "volume": "26", "author": "Gonzalez", "year": "1994", "journal-title": "Clin Pharmacokinet"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB41|cit42", "doi-asserted-by": "crossref", "first-page": "346", "DOI": "10.1016/0165-6147(92)90107-H", "article-title": "Human cytochrome P450:Problems and prospects", "volume": "13", "author": "Gonzalez", "year": "1992", "journal-title": "Trends Pharmacol Sci"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB42|cit43", "doi-asserted-by": "crossref", "first-page": "1871", "DOI": "10.1172/JCI116064", "article-title": "Identification of rifampicin-inducible P450 IIIA4 (CYP3A4) in human small bowel enterocytes", "volume": "90", "author": "Kolars", "year": "1992", "journal-title": "J Clin Invest"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB43|cit44", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1042/bj2810359", "article-title": "Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics", "volume": "281", "author": "Forrester", "year": "1992", "journal-title": "Biochemistry"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB44|cit45", "doi-asserted-by": "crossref", "first-page": "265", "DOI": "10.1038/clpt.1992.140", "article-title": "Comparison of urinary 6-0-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A4) activity", "volume": "52", "author": "Watkins", "year": "1992", "journal-title": "Clin Pharmacol Ther"}, {"key": "10.1111/j.1365-2125.1995.tb04559.x-BIB45|cit46", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.3109/10408449209145319", "article-title": "The human hepatic cytochromes P450 involved in drug metabolism", "volume": "22", "author": "Wrighton", "year": "1992", "journal-title": "Crit Rev Toxicol"}], "container-title": ["British Journal of Clinical Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1995.tb04559.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 20]], "date-time": "2017-06-20T20:55:54Z", "timestamp": 1497992154000}, "score": 25.884512, "issued": {"date-parts": [[1995, 10]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[1995, 10]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1111/j.1365-2125.1995.tb04559.x", "relation": {"cites": []}, "ISSN": ["0306-5251"], "issn-type": [{"value": "0306-5251", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:36:52Z", "timestamp": 1574145412940}, "reference-count": 26, "publisher": "Elsevier BV", "issue": "17", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1989, 9, 1]], "date-time": "1989-09-01T00:00:00Z", "timestamp": 620611200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biochemical Pharmacology"], "published-print": {"date-parts": [[1989, 9]]}, "DOI": "10.1016/0006-2952(89)90441-3", "type": "journal-article", "created": {"date-parts": [[2002, 12, 13]], "date-time": "2002-12-13T22:05:35Z", "timestamp": 1039817135000}, "page": "2853-2858", "source": "Crossref", "is-referenced-by-count": 16, "title": ["Activation of mianserin and its metabolites by human liver microsomes"], "prefix": "10.1016", "volume": "38", "author": [{"given": "C.", "family": "Lambert", "sequence": "first", "affiliation": []}, {"given": "B.K.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "N.R.", "family": "Kitteringham", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Biochemical Pharmacology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0006295289904413?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0006295289904413?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 2]], "date-time": "2019-04-02T02:56:13Z", "timestamp": 1554173773000}, "score": 25.431583, "issued": {"date-parts": [[1989, 9]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[1989, 9]]}, "issue": "17"}, "alternative-id": ["0006295289904413"], "URL": "http://dx.doi.org/10.1016/0006-2952(89)90441-3", "ISSN": ["0006-2952"], "issn-type": [{"value": "0006-2952", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T15:00:35Z", "timestamp": 1574521235156}, "reference-count": 28, "publisher": "Japan Society for Analytical Chemistry", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Anal. Sci."], "published-print": {"date-parts": [[2012]]}, "DOI": "10.2116/analsci.28.1197", "type": "journal-article", "created": {"date-parts": [[2012, 12, 10]], "date-time": "2012-12-10T01:19:55Z", "timestamp": 1355102395000}, "page": "1197-1201", "source": "Crossref", "is-referenced-by-count": 5, "title": ["High-throughput Screening of Inhibitory Effects of Bo-yang-hwan-o-tang on Human Cytochrome P450 Isoforms in vitro Using UPLC/MS/MS"], "prefix": "10.2116", "volume": "28", "author": [{"given": "Miran", "family": "LEE", "sequence": "first", "affiliation": []}, {"given": "Jeonghyeon", "family": "PARK", "sequence": "additional", "affiliation": []}, {"given": "Mi-sun", "family": "LIM", "sequence": "additional", "affiliation": []}, {"given": "Sook Jin", "family": "SEONG", "sequence": "additional", "affiliation": []}, {"given": "Joomi", "family": "LEE", "sequence": "additional", "affiliation": []}, {"given": "Jeong Ju", "family": "SEO", "sequence": "additional", "affiliation": []}, {"given": "Yong-Ki", "family": "PARK", "sequence": "additional", "affiliation": []}, {"given": "Hae Won", "family": "LEE", "sequence": "additional", "affiliation": []}, {"given": "Young-Ran", "family": "YOON", "sequence": "additional", "affiliation": []}], "member": "866", "container-title": ["Analytical Sciences"], "language": "en", "link": [{"URL": "https://www.jstage.jst.go.jp/article/analsci/28/12/28_1197/_pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 7, 6]], "date-time": "2019-07-06T21:22:55Z", "timestamp": 1562448175000}, "score": 24.767366, "issued": {"date-parts": [[2012]]}, "references-count": 28, "journal-issue": {"published-print": {"date-parts": [[2012]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.2116/analsci.28.1197", "ISSN": ["0910-6340", "1348-2246"], "issn-type": [{"value": "0910-6340", "type": "print"}, {"value": "1348-2246", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T15:59:15Z", "timestamp": 1574265555560}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Carcinogenesis"], "published-print": {"date-parts": [[1983]]}, "DOI": "10.1093/carcin/4.5.639", "type": "journal-article", "created": {"date-parts": [[2007, 1, 5]], "date-time": "2007-01-05T07:50:46Z", "timestamp": 1167983446000}, "page": "639-641", "source": "Crossref", "is-referenced-by-count": 9, "title": ["Inhibition of 2-acetylaminofluorene oxidations by monoclonal antibodies specific to 3-methylcholanthrene-induced rat liver cytochrome P450"], "prefix": "10.1093", "volume": "4", "author": [{"given": "S.S.", "family": "Thorgeirsson", "sequence": "first", "affiliation": []}, {"given": "N.", "family": "Sanderson", "sequence": "additional", "affiliation": []}, {"given": "S.S.", "family": "Park", "sequence": "additional", "affiliation": []}, {"given": "H.V.", "family": "Gelboin", "sequence": "additional", "affiliation": []}], "member": "286", "container-title": ["Carcinogenesis"], "language": "en", "link": [{"URL": "http://academic.oup.com/carcin/article-pdf/4/5/639/7092049/4-5-639.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 24]], "date-time": "2017-08-24T13:32:16Z", "timestamp": 1503581536000}, "score": 24.369198, "issued": {"date-parts": [[1983]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1983]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1093/carcin/4.5.639", "ISSN": ["0143-3334", "1460-2180"], "issn-type": [{"value": "0143-3334", "type": "print"}, {"value": "1460-2180", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T01:18:38Z", "timestamp": 1574126318416}, "reference-count": 15, "publisher": "Elsevier", "isbn-type": [{"value": "9780121821739", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[1996]]}, "DOI": "10.1016/s0076-6879(96)72042-6", "type": "book-chapter", "created": {"date-parts": [[2004, 5, 18]], "date-time": "2004-05-18T20:10:15Z", "timestamp": 1084911015000}, "page": "368-377", "source": "Crossref", "is-referenced-by-count": 10, "title": ["[40] Crystallization studies of NADPH-cytochrome P450 reductase"], "prefix": "10.1016", "author": [{"given": "Jung-Ja Park", "family": "Kim", "sequence": "first", "affiliation": []}, {"given": "David L.", "family": "Roberts", "sequence": "additional", "affiliation": []}, {"given": "Snezana", "family": "Djordjevic", "sequence": "additional", "affiliation": []}, {"given": "Miug", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Thomas M.", "family": "Shea", "sequence": "additional", "affiliation": []}, {"given": "Bettie Sue Siler", "family": "Masters", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Methods in Enzymology", "Cytochrome P450, Part B"], "deposited": {"date-parts": [[2019, 2, 9]], "date-time": "2019-02-09T07:50:39Z", "timestamp": 1549698639000}, "score": 23.96009, "issued": {"date-parts": [[1996]]}, "ISBN": ["9780121821739"], "references-count": 15, "URL": "http://dx.doi.org/10.1016/s0076-6879(96)72042-6", "ISSN": ["0076-6879"], "issn-type": [{"value": "0076-6879", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:13:49Z", "timestamp": 1574108029604}, "reference-count": 369, "publisher": "Elsevier BV", "issue": "3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1995, 1, 1]], "date-time": "1995-01-01T00:00:00Z", "timestamp": 788918400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pharmacology & Therapeutics"], "published-print": {"date-parts": [[1995, 1]]}, "DOI": "10.1016/0163-7258(95)02013-6", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T02:08:54Z", "timestamp": 1027649334000}, "page": "385-424", "source": "Crossref", "is-referenced-by-count": 101, "title": ["The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity"], "prefix": "10.1016", "volume": "68", "author": [{"given": "B.Kevin", "family": "Park", "sequence": "first", "affiliation": []}, {"given": "Munir", "family": "Pirmohamed", "sequence": "additional", "affiliation": []}, {"given": "Neil R.", "family": "Kitteringham", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Pharmacology & Therapeutics"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0163725895020136?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0163725895020136?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T00:50:41Z", "timestamp": 1555289441000}, "score": 23.662844, "issued": {"date-parts": [[1995, 1]]}, "references-count": 369, "journal-issue": {"published-print": {"date-parts": [[1995, 1]]}, "issue": "3"}, "alternative-id": ["0163725895020136"], "URL": "http://dx.doi.org/10.1016/0163-7258(95)02013-6", "ISSN": ["0163-7258"], "issn-type": [{"value": "0163-7258", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}